CS
MDT icon

Credit Suisse’s Medtronic MDT Stock Holding History

Credit Suisse’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-145,300
Closed -$15M – 4041
2021
Q4 		$15M Sell
145,300
-99,900
-41% -$11.6M 0.01% 1242
2021
Q3 		$30.7M Sell
245,200
-63,400
-21% -$8.21M 0.02% 873
2021
Q2 		$38.4M Sell
308,600
-335,300
-52% -$42.1M 0.02% 811
2021
Q1 		$76.1M Sell
643,900
-129,500
-17% -$15.2M 0.04% 532
2020
Q4 		$90.6M Buy
773,400
+350,400
+83% +$38.6M 0.04% 455
2020
Q3 		$44M Buy
423,000
+226,700
+115% +$22.8M 0.03% 663
2020
Q2 		$18M Buy
196,300
+129,100
+192% +$12.4M 0.01% 995
2020
Q1 		$6.06M Sell
67,200
-99,600
-60% -$10.6M 0.01% 1438
2019
Q4 		$18.9M Buy
166,800
+56,000
+51% +$6.15M 0.01% 1058
2019
Q3 		$12M Sell
110,800
-22,300
-17% -$2.33M 0.01% 1203
2019
Q2 		$13M Buy
133,100
+6,700
+5% +$612K 0.01% 1162
2019
Q1 		$11.5M Buy
126,400
+102,500
+429% +$9.17M 0.01% 1159
2018
Q4 		$2.17M Sell
23,900
-80,100
-77% -$7.49M ﹤0.01% 2177
2018
Q3 		$10.2M Buy
104,000
+24,000
+30% +$2.22M 0.01% 1244
2018
Q2 		$6.85M Sell
80,000
-55,000
-41% -$4.59M 0.01% 1505
2018
Q1 		$10.8M Buy
135,000
+100,000
+286% +$8.25M 0.01% 1195
2017
Q4 		$2.83M Buy
+35,000
New +$2.8M ﹤0.01% 2176
2017
Q2 		– Sell
-57,500
Closed -$4.63M – 3909
2017
Q1 		$4.63M Buy
+57,500
New +$4.49M ﹤0.01% 1704
2016
Q3 		– Sell
-33,700
Closed -$2.92M – 4193
2016
Q2 		$2.92M Buy
33,700
+26,000
+338% +$2.1M ﹤0.01% 2047
2016
Q1 		$578K Sell
7,700
-27,700
-78% -$2.09M ﹤0.01% 3145
2015
Q4 		$2.72M Buy
+35,400
New +$2.66M ﹤0.01% 2058
2015
Q2 		– Sell
-63,700
Closed -$4.97M – 4593
2015
Q1 		$4.97M Buy
+63,700
New +$4.83M 0.01% 1677
2013
Q3 		– Sell
-1,054,500
Closed -$54.3M – 4306
2013
Q2 		$54.3M Buy
+1,054,500
New +$52.1M 0.05% 349

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse's MDT Position: Q1 2024 in Review

Credit Suisse reduced its Medtronic (MDT) stake by 7.9% in Q1 2024, selling an estimated $12.2M and leaving 1,664,769 shares worth $145M. The position accounts for 0.14% of the portfolio, ranked #134.

Credit Suisse first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $332M in Q4 2019. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Credit Suisse held 1,664,769 shares of Medtronic worth $145M as of Q1 2024.
  • Credit Suisse sold 142,649 Medtronic shares in Q1 2024, an estimated $12.2M.
  • Medtronic made up 0.14% of Credit Suisse's portfolio in Q1 2024, its #134 holding.
  • Credit Suisse first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
  • Credit Suisse's Medtronic position peaked at $332M in Q4 2019.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.